These emerging therapies, including Wegovy, Tirzepatide , and another option, represent a major advancement in addressing type 2 hyperglycemia and supporting weight loss . They work by emulating the body’s natural incretin substance, enabling to moderate blood levels and decrease appetite . The therapy has a few different properties and might be